Serveur d'exploration sur l'agrobacterium et la transgénèse

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Expression of HIV-1 antigens in plants as potential subunit vaccines.

Identifieur interne : 000684 ( Main/Exploration ); précédent : 000683; suivant : 000685

Expression of HIV-1 antigens in plants as potential subunit vaccines.

Auteurs : Ann Meyers [Afrique du Sud] ; Ereck Chakauya ; Enid Shephard ; Fiona L. Tanzer ; James Maclean ; Alisson Lynch ; Anna-Lise Williamson ; Edward P. Rybicki

Source :

RBID : pubmed:18573204

Descripteurs français

English descriptors

Abstract

BACKGROUND

Human immunodeficiency virus type 1 (HIV-1) has infected more than 40 million people worldwide, mainly in sub-Saharan Africa. The high prevalence of HIV-1 subtype C in southern Africa necessitates the development of cheap, effective vaccines. One means of production is the use of plants, for which a number of different techniques have been successfully developed. HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate: we compared the expression of this and a truncated Gag (p17/p24) and the p24 capsid subunit in Nicotiana spp. using transgenic plants and transient expression via Agrobacterium tumefaciens and recombinant tobamovirus vectors. We also investigated the influence of subcellular localisation of recombinant protein to the chloroplast and the endoplasmic reticulum (ER) on protein yield. We partially purified a selected vaccine candidate and tested its stimulation of a humoral and cellular immune response in mice.

RESULTS

Both transient and transgenic expression of the HIV antigens were successful, although expression of Pr55Gag was low in all systems; however, the Agrobacterium-mediated transient expression of p24 and p17/p24 yielded best, to more than 1 mg p24/kg fresh weight. Chloroplast targeted protein levels were highest in transient and transgenic expression of p24 and p17/p24. The transiently-expressed p17/p24 was not immunogenic in mice as a homologous vaccine, but it significantly boosted a humoral and T cell immune response primed by a gag DNA vaccine, pTHGagC.

CONCLUSION

Transient agroinfiltration was best for expression of all of the recombinant proteins tested, and p24 and p17/p24 were expressed at much higher levels than Pr55Gag. Our results highlight the usefulness of plastid signal peptides in enhancing the production of recombinant proteins meant for use as vaccines. The p17/p24 protein effectively boosted T cell and humoral responses in mice primed by the DNA vaccine pTHGagC, showing that this plant-produced protein has potential for use as a vaccine.


DOI: 10.1186/1472-6750-8-53
PubMed: 18573204
PubMed Central: PMC2443125


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Expression of HIV-1 antigens in plants as potential subunit vaccines.</title>
<author>
<name sortKey="Meyers, Ann" sort="Meyers, Ann" uniqKey="Meyers A" first="Ann" last="Meyers">Ann Meyers</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa. ann.meyers@uct.ac.za</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925</wicri:regionArea>
<wicri:noRegion>Observatory 7925</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chakauya, Ereck" sort="Chakauya, Ereck" uniqKey="Chakauya E" first="Ereck" last="Chakauya">Ereck Chakauya</name>
</author>
<author>
<name sortKey="Shephard, Enid" sort="Shephard, Enid" uniqKey="Shephard E" first="Enid" last="Shephard">Enid Shephard</name>
</author>
<author>
<name sortKey="Tanzer, Fiona L" sort="Tanzer, Fiona L" uniqKey="Tanzer F" first="Fiona L" last="Tanzer">Fiona L. Tanzer</name>
</author>
<author>
<name sortKey="Maclean, James" sort="Maclean, James" uniqKey="Maclean J" first="James" last="Maclean">James Maclean</name>
</author>
<author>
<name sortKey="Lynch, Alisson" sort="Lynch, Alisson" uniqKey="Lynch A" first="Alisson" last="Lynch">Alisson Lynch</name>
</author>
<author>
<name sortKey="Williamson, Anna Lise" sort="Williamson, Anna Lise" uniqKey="Williamson A" first="Anna-Lise" last="Williamson">Anna-Lise Williamson</name>
</author>
<author>
<name sortKey="Rybicki, Edward P" sort="Rybicki, Edward P" uniqKey="Rybicki E" first="Edward P" last="Rybicki">Edward P. Rybicki</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:18573204</idno>
<idno type="pmid">18573204</idno>
<idno type="doi">10.1186/1472-6750-8-53</idno>
<idno type="pmc">PMC2443125</idno>
<idno type="wicri:Area/Main/Corpus">000675</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000675</idno>
<idno type="wicri:Area/Main/Curation">000675</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000675</idno>
<idno type="wicri:Area/Main/Exploration">000675</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Expression of HIV-1 antigens in plants as potential subunit vaccines.</title>
<author>
<name sortKey="Meyers, Ann" sort="Meyers, Ann" uniqKey="Meyers A" first="Ann" last="Meyers">Ann Meyers</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa. ann.meyers@uct.ac.za</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925</wicri:regionArea>
<wicri:noRegion>Observatory 7925</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chakauya, Ereck" sort="Chakauya, Ereck" uniqKey="Chakauya E" first="Ereck" last="Chakauya">Ereck Chakauya</name>
</author>
<author>
<name sortKey="Shephard, Enid" sort="Shephard, Enid" uniqKey="Shephard E" first="Enid" last="Shephard">Enid Shephard</name>
</author>
<author>
<name sortKey="Tanzer, Fiona L" sort="Tanzer, Fiona L" uniqKey="Tanzer F" first="Fiona L" last="Tanzer">Fiona L. Tanzer</name>
</author>
<author>
<name sortKey="Maclean, James" sort="Maclean, James" uniqKey="Maclean J" first="James" last="Maclean">James Maclean</name>
</author>
<author>
<name sortKey="Lynch, Alisson" sort="Lynch, Alisson" uniqKey="Lynch A" first="Alisson" last="Lynch">Alisson Lynch</name>
</author>
<author>
<name sortKey="Williamson, Anna Lise" sort="Williamson, Anna Lise" uniqKey="Williamson A" first="Anna-Lise" last="Williamson">Anna-Lise Williamson</name>
</author>
<author>
<name sortKey="Rybicki, Edward P" sort="Rybicki, Edward P" uniqKey="Rybicki E" first="Edward P" last="Rybicki">Edward P. Rybicki</name>
</author>
</analytic>
<series>
<title level="j">BMC biotechnology</title>
<idno type="eISSN">1472-6750</idno>
<imprint>
<date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>AIDS Vaccines (biosynthesis)</term>
<term>AIDS Vaccines (genetics)</term>
<term>Adjuvants, Immunologic (genetics)</term>
<term>Agrobacterium tumefaciens (genetics)</term>
<term>Animals (MeSH)</term>
<term>Chloroplasts (genetics)</term>
<term>Chloroplasts (metabolism)</term>
<term>Endoplasmic Reticulum (genetics)</term>
<term>Endoplasmic Reticulum (metabolism)</term>
<term>Female (MeSH)</term>
<term>Gene Expression (MeSH)</term>
<term>Gene Expression Regulation, Plant (MeSH)</term>
<term>Genes, gag (MeSH)</term>
<term>Genetic Vectors (MeSH)</term>
<term>HIV Antigens (biosynthesis)</term>
<term>HIV Antigens (genetics)</term>
<term>HIV Antigens (immunology)</term>
<term>HIV Infections (immunology)</term>
<term>HIV Seronegativity (MeSH)</term>
<term>HIV-1 (genetics)</term>
<term>Humans (MeSH)</term>
<term>Mice (MeSH)</term>
<term>Mice, Inbred BALB C (MeSH)</term>
<term>Plants, Genetically Modified (MeSH)</term>
<term>Tobacco (genetics)</term>
<term>Tobamovirus (genetics)</term>
<term>Transformation, Genetic (MeSH)</term>
<term>Vaccines, Subunit (biosynthesis)</term>
<term>Vaccines, Subunit (genetics)</term>
<term>gag Gene Products, Human Immunodeficiency Virus (biosynthesis)</term>
<term>gag Gene Products, Human Immunodeficiency Virus (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adjuvants immunologiques (génétique)</term>
<term>Agrobacterium tumefaciens (génétique)</term>
<term>Animaux (MeSH)</term>
<term>Antigènes du VIH (biosynthèse)</term>
<term>Antigènes du VIH (génétique)</term>
<term>Antigènes du VIH (immunologie)</term>
<term>Chloroplastes (génétique)</term>
<term>Chloroplastes (métabolisme)</term>
<term>Expression des gènes (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Gènes gag (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à VIH (immunologie)</term>
<term>Produits du gène gag du virus de l'immunodéficience humaine (biosynthèse)</term>
<term>Produits du gène gag du virus de l'immunodéficience humaine (génétique)</term>
<term>Régulation de l'expression des gènes végétaux (MeSH)</term>
<term>Réticulum endoplasmique (génétique)</term>
<term>Réticulum endoplasmique (métabolisme)</term>
<term>Souris (MeSH)</term>
<term>Souris de lignée BALB C (MeSH)</term>
<term>Séronégativité VIH (MeSH)</term>
<term>Tabac (génétique)</term>
<term>Tobamovirus (génétique)</term>
<term>Transformation génétique (MeSH)</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (génétique)</term>
<term>Vaccins contre le SIDA (biosynthèse)</term>
<term>Vaccins contre le SIDA (génétique)</term>
<term>Vaccins sous-unitaires (biosynthèse)</term>
<term>Vaccins sous-unitaires (génétique)</term>
<term>Vecteurs génétiques (MeSH)</term>
<term>Végétaux génétiquement modifiés (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>AIDS Vaccines</term>
<term>HIV Antigens</term>
<term>Vaccines, Subunit</term>
<term>gag Gene Products, Human Immunodeficiency Virus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>AIDS Vaccines</term>
<term>Adjuvants, Immunologic</term>
<term>HIV Antigens</term>
<term>Vaccines, Subunit</term>
<term>gag Gene Products, Human Immunodeficiency Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr">
<term>Antigènes du VIH</term>
<term>Produits du gène gag du virus de l'immunodéficience humaine</term>
<term>Vaccins contre le SIDA</term>
<term>Vaccins sous-unitaires</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Agrobacterium tumefaciens</term>
<term>Chloroplasts</term>
<term>Endoplasmic Reticulum</term>
<term>HIV-1</term>
<term>Tobacco</term>
<term>Tobamovirus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Adjuvants immunologiques</term>
<term>Agrobacterium tumefaciens</term>
<term>Antigènes du VIH</term>
<term>Chloroplastes</term>
<term>Produits du gène gag du virus de l'immunodéficience humaine</term>
<term>Réticulum endoplasmique</term>
<term>Tabac</term>
<term>Tobamovirus</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
<term>Vaccins contre le SIDA</term>
<term>Vaccins sous-unitaires</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Antigènes du VIH</term>
<term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>HIV Antigens</term>
<term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Chloroplasts</term>
<term>Endoplasmic Reticulum</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Chloroplastes</term>
<term>Réticulum endoplasmique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Female</term>
<term>Gene Expression</term>
<term>Gene Expression Regulation, Plant</term>
<term>Genes, gag</term>
<term>Genetic Vectors</term>
<term>HIV Seronegativity</term>
<term>Humans</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Plants, Genetically Modified</term>
<term>Transformation, Genetic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Expression des gènes</term>
<term>Femelle</term>
<term>Gènes gag</term>
<term>Humains</term>
<term>Régulation de l'expression des gènes végétaux</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Séronégativité VIH</term>
<term>Transformation génétique</term>
<term>Vecteurs génétiques</term>
<term>Végétaux génétiquement modifiés</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>Human immunodeficiency virus type 1 (HIV-1) has infected more than 40 million people worldwide, mainly in sub-Saharan Africa. The high prevalence of HIV-1 subtype C in southern Africa necessitates the development of cheap, effective vaccines. One means of production is the use of plants, for which a number of different techniques have been successfully developed. HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate: we compared the expression of this and a truncated Gag (p17/p24) and the p24 capsid subunit in Nicotiana spp. using transgenic plants and transient expression via Agrobacterium tumefaciens and recombinant tobamovirus vectors. We also investigated the influence of subcellular localisation of recombinant protein to the chloroplast and the endoplasmic reticulum (ER) on protein yield. We partially purified a selected vaccine candidate and tested its stimulation of a humoral and cellular immune response in mice.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>Both transient and transgenic expression of the HIV antigens were successful, although expression of Pr55Gag was low in all systems; however, the Agrobacterium-mediated transient expression of p24 and p17/p24 yielded best, to more than 1 mg p24/kg fresh weight. Chloroplast targeted protein levels were highest in transient and transgenic expression of p24 and p17/p24. The transiently-expressed p17/p24 was not immunogenic in mice as a homologous vaccine, but it significantly boosted a humoral and T cell immune response primed by a gag DNA vaccine, pTHGagC.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSION</b>
</p>
<p>Transient agroinfiltration was best for expression of all of the recombinant proteins tested, and p24 and p17/p24 were expressed at much higher levels than Pr55Gag. Our results highlight the usefulness of plastid signal peptides in enhancing the production of recombinant proteins meant for use as vaccines. The p17/p24 protein effectively boosted T cell and humoral responses in mice primed by the DNA vaccine pTHGagC, showing that this plant-produced protein has potential for use as a vaccine.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">18573204</PMID>
<DateCompleted>
<Year>2008</Year>
<Month>09</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1472-6750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>8</Volume>
<PubDate>
<Year>2008</Year>
<Month>Jun</Month>
<Day>23</Day>
</PubDate>
</JournalIssue>
<Title>BMC biotechnology</Title>
<ISOAbbreviation>BMC Biotechnol</ISOAbbreviation>
</Journal>
<ArticleTitle>Expression of HIV-1 antigens in plants as potential subunit vaccines.</ArticleTitle>
<Pagination>
<MedlinePgn>53</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/1472-6750-8-53</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Human immunodeficiency virus type 1 (HIV-1) has infected more than 40 million people worldwide, mainly in sub-Saharan Africa. The high prevalence of HIV-1 subtype C in southern Africa necessitates the development of cheap, effective vaccines. One means of production is the use of plants, for which a number of different techniques have been successfully developed. HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate: we compared the expression of this and a truncated Gag (p17/p24) and the p24 capsid subunit in Nicotiana spp. using transgenic plants and transient expression via Agrobacterium tumefaciens and recombinant tobamovirus vectors. We also investigated the influence of subcellular localisation of recombinant protein to the chloroplast and the endoplasmic reticulum (ER) on protein yield. We partially purified a selected vaccine candidate and tested its stimulation of a humoral and cellular immune response in mice.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Both transient and transgenic expression of the HIV antigens were successful, although expression of Pr55Gag was low in all systems; however, the Agrobacterium-mediated transient expression of p24 and p17/p24 yielded best, to more than 1 mg p24/kg fresh weight. Chloroplast targeted protein levels were highest in transient and transgenic expression of p24 and p17/p24. The transiently-expressed p17/p24 was not immunogenic in mice as a homologous vaccine, but it significantly boosted a humoral and T cell immune response primed by a gag DNA vaccine, pTHGagC.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Transient agroinfiltration was best for expression of all of the recombinant proteins tested, and p24 and p17/p24 were expressed at much higher levels than Pr55Gag. Our results highlight the usefulness of plastid signal peptides in enhancing the production of recombinant proteins meant for use as vaccines. The p17/p24 protein effectively boosted T cell and humoral responses in mice primed by the DNA vaccine pTHGagC, showing that this plant-produced protein has potential for use as a vaccine.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Meyers</LastName>
<ForeName>Ann</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa. ann.meyers@uct.ac.za</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chakauya</LastName>
<ForeName>Ereck</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shephard</LastName>
<ForeName>Enid</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tanzer</LastName>
<ForeName>Fiona L</ForeName>
<Initials>FL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Maclean</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lynch</LastName>
<ForeName>Alisson</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Williamson</LastName>
<ForeName>Anna-Lise</ForeName>
<Initials>AL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rybicki</LastName>
<ForeName>Edward P</ForeName>
<Initials>EP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2008</Year>
<Month>06</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMC Biotechnol</MedlineTA>
<NlmUniqueID>101088663</NlmUniqueID>
<ISSNLinking>1472-6750</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016915">AIDS Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000276">Adjuvants, Immunologic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015488">HIV Antigens</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D022223">Vaccines, Subunit</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054301">gag Gene Products, Human Immunodeficiency Virus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D016915" MajorTopicYN="N">AIDS Vaccines</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000276" MajorTopicYN="N">Adjuvants, Immunologic</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016960" MajorTopicYN="N">Agrobacterium tumefaciens</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002736" MajorTopicYN="N">Chloroplasts</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004721" MajorTopicYN="N">Endoplasmic Reticulum</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018506" MajorTopicYN="N">Gene Expression Regulation, Plant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015750" MajorTopicYN="Y">Genes, gag</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015488" MajorTopicYN="N">HIV Antigens</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018023" MajorTopicYN="N">HIV Seronegativity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D030821" MajorTopicYN="N">Plants, Genetically Modified</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014026" MajorTopicYN="N">Tobacco</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017898" MajorTopicYN="N">Tobamovirus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014170" MajorTopicYN="N">Transformation, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D022223" MajorTopicYN="N">Vaccines, Subunit</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054301" MajorTopicYN="N">gag Gene Products, Human Immunodeficiency Virus</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2007</Year>
<Month>11</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2008</Year>
<Month>06</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2008</Year>
<Month>6</Month>
<Day>25</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2008</Year>
<Month>9</Month>
<Day>3</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2008</Year>
<Month>6</Month>
<Day>25</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">18573204</ArticleId>
<ArticleId IdType="pii">1472-6750-8-53</ArticleId>
<ArticleId IdType="doi">10.1186/1472-6750-8-53</ArticleId>
<ArticleId IdType="pmc">PMC2443125</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Trends Plant Sci. 2001 May;6(5):219-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11335175</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1993 Oct 14;365(6447):666-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8105392</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1997 May 27;94(11):5784-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9159151</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2004 Aug;4(8):595-602</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15286726</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13584-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15347807</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br Med J (Clin Res Ed). 1987 Sep 5;295(6598):569-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3117235</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2006 Sep;120(1-2):91-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16530873</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 2002 Dec 4;532(1-2):75-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12459466</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Protein Expr Purif. 2003 Nov;32(1):10-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14680934</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2006 Feb;87(Pt 2):399-410</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16432028</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rev Med Virol. 2005 Mar-Apr;15(2):75-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15484204</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Methods Mol Biol. 2005;286:111-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15310917</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Plant J. 2003 Mar;33(5):949-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12609035</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biotechnol Appl Biochem. 1999 Oct;30 ( Pt 2):113-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10512789</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AIDS Res Hum Retroviruses. 2002 Sep 20;18(14):999-1010</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12396452</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Biotechnol. 2000 Feb;14(2):99-107</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10872503</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Parasitol. 2003 May;33(5-6):479-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12782049</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Plant Biotechnol J. 2006 Mar;4(2):195-207</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17177796</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 1991 Jan 5;302(6767):23-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1899349</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2002 Aug 19;20(25-26):3155-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12163267</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17525-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16278301</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Plant Biotechnol J. 2005 Nov;3(6):613-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17147632</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AIDS Res Hum Retroviruses. 2004 Dec;20(12):1335-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15650426</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Plant Sci. 2005 Dec;10(12):580-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16290220</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Methods. 2006 Sep;40(1):66-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16997715</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1989 Oct 6;59(1):103-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2676191</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Biotechnol. 2003 Dec;21(12):570-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14624867</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Plant Biol. 2004 Apr;7(2):152-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15003215</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3378-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15728371</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol Methods. 2004 Nov;121(2):201-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15381357</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2005 Mar 7;23(15):1851-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15734055</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2003 Oct 1;21(27-30):4380-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14505921</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2004 Feb;85(Pt 2):409-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14769898</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Plant Biol. 2004 Apr;7(2):182-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15003219</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2002 Oct;76(20):10155-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12239290</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2006 Mar 24;24(14):2506-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16417953</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2005 Mar 7;23(15):1875-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15734059</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Plant Cell Rep. 2004 Jan;22(6):382-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14551730</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AIDS Res Hum Retroviruses. 1995 Mar;11(3):327-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7786579</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 1997 Jun;78 ( Pt 6):1213-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9191910</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 1985 Mar 8;227(4691):1229-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17757866</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Plant Biotechnol J. 2004 May;2(3):241-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17147615</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Immunol. 2004 Sep;5(9):927-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15300249</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2001 Sep;75(18):8434-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11507188</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Feb;77(3):2081-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12525643</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11088-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15258286</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>IUBMB Life. 2002 Apr-May;53(4-5):207-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12120996</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 May 4;101(18):6852-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15103020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2004 Oct 22;22(31-32):4374-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15474731</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2007 May;88(Pt 5):1460-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17412974</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Jan;77(2):882-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12502804</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2000 Jan;74(1):16-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10590086</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1994 Mar;68(3):1689-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8107229</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):9062-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15956182</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Appl Environ Microbiol. 2002 Jul;68(7):3345-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12089013</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Immunol. 2005 Feb;42(2):259-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15488613</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Afrique du Sud</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Chakauya, Ereck" sort="Chakauya, Ereck" uniqKey="Chakauya E" first="Ereck" last="Chakauya">Ereck Chakauya</name>
<name sortKey="Lynch, Alisson" sort="Lynch, Alisson" uniqKey="Lynch A" first="Alisson" last="Lynch">Alisson Lynch</name>
<name sortKey="Maclean, James" sort="Maclean, James" uniqKey="Maclean J" first="James" last="Maclean">James Maclean</name>
<name sortKey="Rybicki, Edward P" sort="Rybicki, Edward P" uniqKey="Rybicki E" first="Edward P" last="Rybicki">Edward P. Rybicki</name>
<name sortKey="Shephard, Enid" sort="Shephard, Enid" uniqKey="Shephard E" first="Enid" last="Shephard">Enid Shephard</name>
<name sortKey="Tanzer, Fiona L" sort="Tanzer, Fiona L" uniqKey="Tanzer F" first="Fiona L" last="Tanzer">Fiona L. Tanzer</name>
<name sortKey="Williamson, Anna Lise" sort="Williamson, Anna Lise" uniqKey="Williamson A" first="Anna-Lise" last="Williamson">Anna-Lise Williamson</name>
</noCountry>
<country name="Afrique du Sud">
<noRegion>
<name sortKey="Meyers, Ann" sort="Meyers, Ann" uniqKey="Meyers A" first="Ann" last="Meyers">Ann Meyers</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/AgrobacTransV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000684 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000684 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    AgrobacTransV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:18573204
   |texte=   Expression of HIV-1 antigens in plants as potential subunit vaccines.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:18573204" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AgrobacTransV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Fri Nov 20 15:45:55 2020. Site generation: Wed Mar 6 15:24:41 2024